Clinical Trial Update: Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in Vivo [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating correlation between immunoglobulin and liposomal doxorubicin in vivo for advanced malignant tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Tumor

Drugs mentioned

• liposomal doxorubicin (doxorubicin liposomal)

Snippet

Sponsor: Fudan University | Conditions: Advanced Malignant Tumors | Phase 2 | Status: UNKNOWN